| 000 | 01736 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513213319.0 | ||
| 264 | 0 | _c20000725 | |
| 008 | 200007s 0 0 eng d | ||
| 022 | _a0022-2836 | ||
| 024 | 7 |
_a10.1006/jmbi.2000.3745 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aClement, J Q | |
| 245 | 0 | 0 |
_aRapid induction of nuclear transcripts and inhibition of intron decay in response to the polymerase II inhibitor DRB. _h[electronic resource] |
| 260 |
_bJournal of molecular biology _cJun 2000 |
||
| 300 |
_a1179-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aCell Nucleus _xdrug effects |
| 650 | 0 | 4 |
_aDactinomycin _xpharmacology |
| 650 | 0 | 4 |
_aDichlororibofuranosylbenzimidazole _xpharmacology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aGenes _xgenetics |
| 650 | 0 | 4 |
_aGenes, T-Cell Receptor beta _xgenetics |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntrons _xgenetics |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xgenetics |
| 650 | 0 | 4 |
_aRNA Polymerase II _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRNA Precursors _xbiosynthesis |
| 650 | 0 | 4 |
_aRNA Processing, Post-Transcriptional _xdrug effects |
| 650 | 0 | 4 |
_aRNA Stability _xdrug effects |
| 650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 650 | 0 | 4 |
_aTetracycline _xpharmacology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTranscription, Genetic _xdrug effects |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 700 | 1 | _aWilkinson, M F | |
| 773 | 0 |
_tJournal of molecular biology _gvol. 299 _gno. 5 _gp. 1179-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/jmbi.2000.3745 _zAvailable from publisher's website |
| 999 |
_c10824162 _d10824162 |
||